{"id":"https://openalex.org/W1985757207","doi":"https://doi.org/10.1097/00008877-199206000-00011","title":"Memantine has phencyclidine-like but not cocaine-like discriminative stimulus effects in rats","display_name":"Memantine has phencyclidine-like but not cocaine-like discriminative stimulus effects in rats","publication_year":1992,"publication_date":"1992-06-01","ids":{"openalex":"https://openalex.org/W1985757207","doi":"https://doi.org/10.1097/00008877-199206000-00011","mag":"1985757207","pmid":"https://pubmed.ncbi.nlm.nih.gov/11224125"},"language":"en","primary_location":{"id":"doi:10.1097/00008877-199206000-00011","doi":"https://doi.org/10.1097/00008877-199206000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008877-199206000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S9181514","display_name":"Behavioural Pharmacology","issn_l":"0955-8810","issn":["0955-8810","1473-5849"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111530371","display_name":"David J. Sanger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. J. Sanger","raw_affiliation_strings":["Synthelabo Recherche (LERS), 31 avenue PV Couturier, 92220 - Bagneux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synthelabo Recherche (LERS), 31 avenue PV Couturier, 92220 - Bagneux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042018278","display_name":"Philip Terry","orcid":"https://orcid.org/0000-0002-3865-9121","observed_orcids":["https://orcid.org/0000-0002-3865-9121"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Terry","raw_affiliation_strings":["NIDA Addiction Research Center, PO Box 5180, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIDA Addiction Research Center, PO Box 5180, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053763901","display_name":"Jonathan L. Katz","orcid":"https://orcid.org/0000-0002-1068-1159","observed_orcids":["https://orcid.org/0000-0002-1068-1159"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. L. Katz","raw_affiliation_strings":["NIDA Addiction Research Center, PO Box 5180, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIDA Addiction Research Center, PO Box 5180, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6732,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.63544381,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"3","issue":"3","first_page":"265???268","last_page":"265???268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7080000042915344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7080000042915344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.26980000734329224,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":1.0},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9380000233650208},{"id":"https://openalex.org/keywords/cocaine","display_name":"cocaine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/discriminative-stimulus-effects","display_name":"discriminative stimulus effects","score":0.9269999861717224},{"id":"https://openalex.org/keywords/nmda-receptor-antagonism","display_name":"NMDA receptor antagonism","score":0.8939999938011169},{"id":"https://openalex.org/keywords/non-competitive-inhibition","display_name":"non-competitive inhibition","score":0.765999972820282},{"id":"https://openalex.org/keywords/amantadine","display_name":"amantadine","score":0.8709999918937683},{"id":"https://openalex.org/keywords/substitution","display_name":"substitution","score":0.4390000104904175},{"id":"https://openalex.org/keywords/drug-discrimination","display_name":"drug discrimination","score":0.4650000035762787},{"id":"https://openalex.org/keywords/parkinsonism-treatment","display_name":"parkinsonism treatment","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.9664029479026794},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.8157491087913513},{"id":"https://openalex.org/C57022672","wikidata":"https://www.wikidata.org/wiki/Q7617378","display_name":"Stimulus control","level":3,"score":0.6787527799606323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5338292121887207},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4943211078643799},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45023074746131897},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.41521257162094116},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4028421640396118},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.23762813210487366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10373860597610474},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08004674315452576},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/00008877-199206000-00011","doi":"https://doi.org/10.1097/00008877-199206000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008877-199206000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S9181514","display_name":"Behavioural Pharmacology","issn_l":"0955-8810","issn":["0955-8810","1473-5849"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural Pharmacology","raw_type":"journal-article"},{"id":"pmid:11224125","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11224125","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8199999928474426}],"sustainable_development_goals_aurora":[{"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10","score":0.75}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2408632495","https://openalex.org/W2064447016","https://openalex.org/W2071828273","https://openalex.org/W3084035900","https://openalex.org/W2001721703","https://openalex.org/W2794202340","https://openalex.org/W1966423911","https://openalex.org/W1819848802","https://openalex.org/W2155567759","https://openalex.org/W1972660098"],"abstract_inverted_index":{"It":[0],"has":[1,18,84],"recently":[2],"been":[3],"reported":[4],"that":[5,82,93],"the":[6,14,28,40,94],"amantadine":[7,62],"derivative,":[8],"memantine,":[9,98],"which":[10],"is":[11],"used":[12],"in":[13],"treatment":[15],"of":[16,31,97,101,110],"Parkinsonism,":[17],"N-methyl-D-aspartate":[19],"(NMDA)":[20],"antagonist":[21],"properties.":[22],"In":[23,68],"order":[24],"to":[25,44,47,71],"investigate":[26],"whether":[27],"behavioural":[29,95],"effects":[30,91],"memantine":[32,75,83],"could":[33],"also":[34],"be":[35],"mediated":[36],"through":[37],"this":[38],"mechanism":[39],"drug":[41],"was":[42],"administered":[43],"rats":[45,69],"trained":[46,70],"discriminate":[48,72],"phencyclidine":[49],"(3mg/kg)":[50],"from":[51],"saline.":[52],"Memantine":[53],"produced":[54,105],"a":[55,107],"dose-related":[56],"(2.5-10mg/kg)":[57],"substitution":[58],"for":[59,66],"phencyclidine.":[60,67],"Neither":[61],"nor":[63],"cocaine":[64,73],"substituted":[65],"(10mg/kg)":[74],"did":[76],"not":[77,87],"substitute.":[78],"These":[79],"results":[80],"show":[81],"phencyclidine-like":[85],"but":[86],"cocaine-like":[88],"discriminative":[89],"stimulus":[90],"indicating":[92],"actions":[96],"like":[99],"those":[100],"phencyclidine,":[102],"are":[103],"probably":[104],"by":[106],"non-competitive":[108],"inhibition":[109],"NMDA":[111],"receptors.":[112]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2016-06-24T00:00:00"}